Abstract
The purpose of this document is to provide a set of recommendations on therapeutic interchange and substitution of pharmaceutical products, including with biosimilars.
Original language | English |
---|---|
Place of Publication | The Hague, Netherlands |
Publisher | International Pharmaceutical Federation |
Number of pages | 7 |
Publication status | Published - 2 Sep 2018 |
Keywords
- Policy statement
- pharmaceutical selection
- Drug selection
- interchange
- substitution
- pharmacist